We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies. Close

US Dimension

Liability Risk and Insurance

US Dimension

Johnson & Johnson in US$263 million opioid settlement with State of New York

Johnson & Johnson and its US-based Janssen Pharmaceutical Companies have revealed a US$263 million settlement agreement with the State of New York and its participating subdivisions, including Nassau County and Suffolk County, resolving their opioid-related claims against the company. With this agreement, the company said it had been removed from the trial that had been scheduled to begin at the end of June.

The rest of this document is only available to i-law.com online subscribers.

If you are already a subscriber, please enter your details below to log in.

Enter your email address to log in as a user on your corporate account.
Remember me on this computer

Not yet an i-law subscriber?

Devices

Request a trial Find out more